Press-release for stocks publishing date 2021 - 08

Prices are updated after-hours

therapeutics publishing date : 2021 - 08 - 03

save search

Regulus Therapeutics Announces Timing for Second Quarter 2021 Financial Results Webcast and Conference Call
Published: 2021-08-03 (Crawled : 22:00) - biospace.com/
RGLS | $2.77 -1.07% -1.08% 310K

Health Technology

| 261.04% | O: -2.4% H: 2.77% C: -0.19%
financial results results conference

Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021
Published: 2021-08-03 (Crawled : 22:00) - biospace.com/
RAIN | $1.21 0.0% 3.7M

Manufacturing

| -92.37% | O: 0.25% H: 3.77% C: 0.13%
financial results results

Monopar Announces FDA Clearance to Proceed with Camsirubicin Clinical Trial Targeting Advanced Soft Tissue Sarcoma
Published: 2021-08-03 (Crawled : 22:00) - biospace.com/
MNPR | $0.752 -3.71% -3.86% 100K

Health Technology

| -85.81% | O: 4.32% H: 5.95% C: 0.54%
fda clearance fda trial clearance soft tissue

Aquestive Therapeutics Reports Second Quarter 2021 Financial Results, Provides Business Update and Raises Full Year Revenue Guidance
Published: 2021-08-03 (Crawled : 22:00) - globenewswire.com
AQST | $3.93 0.51% 0.51% 1.3M

Health Technology

| 21.23% | O: 7.21% H: 12.5% C: 5.61%
financial results results ev

Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Published: 2021-08-03 (Crawled : 21:00) - biospace.com/
TNYA | $4.47 0.22% 0.22% 280K

| -75.6% | O: -1.75% H: 4.17% C: 1.17%
MS | $86.99 0.93% -0.26% 9.5M

Finance

| -8.76% | O: 0.54% H: 0.29% C: -0.16%
offering

Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-08-03 (Crawled : 21:00) - globenewswire.com
NBRV | $1.42 1.39% 720K

Health Technology

| 16.39% | O: 0.82% H: 0.81% C: -1.63%
granted grant nasdaq

Sorrento Mexico and the National Institute of Genomic Medicine (INMEGEN) of Mexico Government Execute Memorandum of Understanding (MOU) for Rapid Clinical Development of COVID-19 Diagnostics
Published: 2021-08-03 (Crawled : 15:00) - biospace.com/
SRNE | $0.3073 -20.27% -8.85% 0

Health Technology

| -99.6% | O: -0.48% H: 0.72% C: -1.33%
covid genomic diagnostics diagnostic

Pliant Therapeutics to Participate in the BTIG Biotechnology Conference
Published: 2021-08-03 (Crawled : 14:15) - biospace.com/
PLRX | $13.55 -4.24% -4.43% 270K

Health Technology

| -37.84% | O: 0.83% H: 1.36% C: -1.82%
biotech technology iot conference therapeutics

Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference
Published: 2021-08-03 (Crawled : 14:15) - biospace.com/
FHTX | $6.395 -20.06% -25.1% 68K

Health Technology

| -28.44% | O: 0.67% H: 0.0% C: -3.34%
conference

SpringWorks Therapeutics to Present at the 12th Annual Wedbush PacGrow Healthcare Conference
Published: 2021-08-03 (Crawled : 14:15) - biospace.com/
SWTX | $42.55 -0.47% -0.47% 560K

Health Technology

| -50.17% | O: 0.15% H: 1.09% C: 0.21%
conference

Increasing Adoption of Targeted Cancer Therapies to Propel Oncolytic Virus Immunotherapy Market, Says TMR
Published: 2021-08-03 (Crawled : 13:15) - prnewswire.com
SRNE | $0.3073 -20.27% -8.85% 0

Health Technology

| -99.6% | O: -0.48% H: 0.72% C: -1.33%
REPL | $7.13 -0.14% -0.14% 670K

Health Technology

| -78.65% | O: 0.84% H: 3.45% C: 1.78%
ONCR | $0.126 -75.95% 140K

Health Technology

| -98.97% | O: -0.24% H: 1.98% C: -1.74%
immunotherapy therapy cancer

Zymeworks Announces Milestone Payment as Janssen Achieves First Patient Dosed for its Bispecific Antibody Utilizing Zymeworks’ Azymetric™ and EFECT™ Therapeutic Platforms
Published: 2021-08-03 (Crawled : 13:15) - biospace.com/
ZYME | $9.09 -1.73% -1.76% 330K

Health Technology

| -71.63% | O: 0.87% H: 0.32% C: -1.14%
antibody milestone

Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference
Published: 2021-08-03 (Crawled : 13:15) - biospace.com/
TNGX | $7.33 -0.41% -0.41% 320K

| Email alert Add to watchlist
conference

Karyopharm Announces Upcoming Virtual Investor Conference Participation - Aug 03, 2021
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
KPTI | $1.155 -5.33% -5.63% 810K

Health Technology

| -86.28% | O: 0.36% H: 0.36% C: -8.05%
conference

Arcturus Announces Approval of Singapore Clinical Trial Application to Advance ARCT-154 and ARCT-165, Next Generation STARR™ mRNA Vaccines Targeting SARS-CoV-2 Variants of Concern, in a Phase 1/2 Study
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
TAK | $13.18 -1.42% 0.0% 1.8M

Health Technology

| -21.27% | O: -0.06% H: 0.0% C: -0.6%
JNJ | $147.59 0.05% 0.0% 8.5M

Health Technology

| -14.33% | O: 0.27% H: 1.02% C: 0.96%
ARCT 4 | $29.31 -3.68% -3.82% 610K

Health Technology

| -15.44% | O: 13.79% H: 51.6% C: 47.69%
phase 1 vaccine trial approval sars-cov-2

ESPERION Reports Second Quarter 2021 Financial Results and Provides Company Update
Published: 2021-08-03 (Crawled : 12:00) - globenewswire.com
ESPR | $1.93 -16.45% -19.69% 6.8M

Health Technology

| -87.09% | O: 4.6% H: 1.34% C: -8.99%
financial results results

iTeos Therapeutics to Present at Wedbush PacGrow Healthcare Conference 2021
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
ITOS | $11.73 0.09% 0.09% 130K

Health Technology

| -52.37% | O: -0.2% H: 0.89% C: 0.61%
conference therapeutics

ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
ADCT | $4.37 -0.46% 0.0% 460K

Health Technology

| -78.9% | O: 3.04% H: 7.22% C: 5.67%
financial results results

Seres Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
MCRB | $0.6194 -5.39% -5.7% 3.8M

Health Technology

| -91.21% | O: 2.28% H: 0.0% C: -3.2%
financial results results

Ryvu Therapeutics to participate in upcoming global investor conferences
Published: 2021-08-03 (Crawled : 11:00) - prnewswire.com
MS | $86.99 0.93% -0.26% 9.5M

Finance